nice tirzepatide obesity Recommends Tirzepatide: A Game-Changer for Management 🔵Eligibility Criteria: ▪️BMI ≥35 kg/m² + at least 1 weight-related comorbidity. ▪️Lower BMI thresholds for specific ethnic groups. 🔵Continuation of Treatment: ▪️≥5% weight loss NICE (UK) positive for Zepbound

It is approved for weight management and type 2 diabetes treatment

In addition, Knapen (221) also found that the use of incretin drugs could increase the risk of pancreatic cancer by 1.7 times

Approved generic medicines are manufactured according to pharmaceutical quality standards and are intended to provide comparable therapeutic effects when prescribed by a qualified healthcare professional

How to Choose a Weight Loss Provider Searching online for a GLP-1 weight loss clinic near me often produces dozens of results

In a study from 2025, the authors compared the Wegovy pill and injection and found that their effectiveness was comparable